Avidity Biosciences (RNA) is up 42.5%, or $20.88 to $70.03.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNA:
- Avidity Biosciences downgraded to Neutral from Buy at Citi
- Avidity Biosciences downgraded to Market Perform from Outperform at Leerink
- Avidity Biosciences rises 42.8%
- Morning Movers: Keurig Dr Pepper jumps after third quarter results
- Avidity acquisition has positive read for Dyne Therapeutics, says Morgan Stanley